<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38">
 <label>38.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Fuenmayor</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gòdia</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cervera</surname>
    <given-names>L</given-names>
   </name>
  </person-group>
  <year>2017</year>
  <article-title>Production of virus-like particles for vaccines</article-title>. 
  <source>N Biotechnol</source>
  <volume>39</volume>
  <comment>(Part B)</comment>:
  <fpage>174</fpage>–
  <lpage>180</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.nbt.2017.07.010</pub-id>.
  <pub-id pub-id-type="pmid">28778817</pub-id>
 </mixed-citation>
</ref>
